Hait WN - Search Results

1

The individualization of cancer therapy: the unexpected role of p53.

Hait WN, Yang JM. Hait WN, et al. Trans Am Clin Climatol Assoc. 2006;117:85-101; discussion 101. Trans Am Clin Climatol Assoc. 2006. PMID: 18528466 Free PMC article. Review.

2

Effect of the multidrug resistance protein on the transport of the antiandrogen flutamide.

Grzywacz MJ, Yang JM, Hait WN. Grzywacz MJ, et al. Among authors: hait wn. Cancer Res. 2003 May 15;63(10):2492-8. Cancer Res. 2003. PMID: 12750271

3

Clinical management of recurrent breast cancer: development of multidrug resistance (MDR) and strategies to circumvent it.

Hait WN, Yang JM. Hait WN, et al. Semin Oncol. 2005 Dec;32(6 Suppl 7):S16-21. doi: 10.1053/j.seminoncol.2005.09.011. Semin Oncol. 2005. PMID: 16360718 Review.

4

A matter of life or death (or both): understanding autophagy in cancer.

Hait WN, Jin S, Yang JM. Hait WN, et al. Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):1961-5. doi: 10.1158/1078-0432.CCR-06-0011. Clin Cancer Res. 2006. PMID: 16609004 Review. No abstract available.

5

Reversal of stathmin-mediated resistance to paclitaxel and vinblastine in human breast carcinoma cells.

Alli E, Yang JM, Ford JM, Hait WN. Alli E, et al. Among authors: hait wn. Mol Pharmacol. 2007 May;71(5):1233-40. doi: 10.1124/mol.106.029702. Epub 2007 Feb 1. Mol Pharmacol. 2007. PMID: 17272681

6

A Phase I/pilot study of sequential doxorubicin/vinorelbine: effects on p53 and microtubule-associated protein 4.

Bash-Babula J, Toppmeyer D, Labassi M, Reidy J, Orlick M, Senzon R, Alli E, Kearney T, August D, Shih W, Yang JM, Hait WN. Bash-Babula J, et al. Among authors: hait wn. Clin Cancer Res. 2002 May;8(5):1057-64. Clin Cancer Res. 2002. PMID: 12006519 Clinical Trial.

7

Effect of stathmin on the sensitivity to antimicrotubule drugs in human breast cancer.

Alli E, Bash-Babula J, Yang JM, Hait WN. Alli E, et al. Among authors: hait wn. Cancer Res. 2002 Dec 1;62(23):6864-9. Cancer Res. 2002. PMID: 12460900

8

The role of MAP4 expression in the sensitivity to paclitaxel and resistance to vinca alkaloids in p53 mutant cells.

Zhang CC, Yang JM, White E, Murphy M, Levine A, Hait WN. Zhang CC, et al. Among authors: hait wn. Oncogene. 1998 Mar 26;16(12):1617-24. doi: 10.1038/sj.onc.1201658. Oncogene. 1998. PMID: 9569030

9

The expression of drug resistance gene products during the progression of human prostate cancer.

Sullivan GF, Amenta PS, Villanueva JD, Alvarez CJ, Yang JM, Hait WN. Sullivan GF, et al. Among authors: hait wn. Clin Cancer Res. 1998 Jun;4(6):1393-403. Clin Cancer Res. 1998. PMID: 9626455

10

DNA damage increases sensitivity to vinca alkaloids and decreases sensitivity to taxanes through p53-dependent repression of microtubule-associated protein 4.

Zhang CC, Yang JM, Bash-Babula J, White E, Murphy M, Levine AJ, Hait WN. Zhang CC, et al. Among authors: hait wn. Cancer Res. 1999 Aug 1;59(15):3663-70. Cancer Res. 1999. PMID: 10446979

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

140 results

Search Page

Filters